drugset / Trial / NCT05223010

Melatonin for Pediatric Emergence Agitation

NCT05223010

Phase 4 Completed 117 enrolled Menoufia University
RandomizedParallel-groupTriple-blindSupportive care

Summary

efficacy of melatonin premedication on emergence agitation in children undergoing herniorrhaphy surgeries

Timeline

Start
2022-01-30
Primary completion
2022-06-02
Completion
2022-12-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Melatonin Small molecule 0.05 mg/kg Oral
Comparator Melatonin Small molecule 0.2 mg/kg Oral
Comparator Melatonin Small molecule 0.4 mg/kg Oral
Comparator Sevoflurane Other / unclassified Inhaled

Indications

No indication recorded.